MedPath

Post Marketing clinical study on surgical wound dressing

Phase 4
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2020/06/026207
Lead Sponsor
Neosoteria Bandages Pvt Ltd
Brief Summary

This open label post marketing study is proposed to be conducted to evaluate the efficacy and safety of DRONAID dressing (Activated Charcoal Absorption Gauge) as compared to Saline Gauge Dressing  on surgical wound

 The study protocol will be reviewed and approved by Institutional Ethics Committee prior to the initiation of the trial at the Investigator’s Site.

50 subjects will be enrolled and randomized into two arms, in 1: 1 ratio. One arm will be getting Dronaid dressing and the other arm will be given Saline gauge. The subjects will be evaluated at the time of Inclusion in the study, subjects who undergo major/minor surgical procedures will be mainly included in the study. The subjects of both the gender between the age group of 18-60 yrs will be taken once they voluntarily sign the informed consent in front of the Principle Investigator.

Before applying the dressing over the wound, the wound will be evaluated by the Investigator as per the wound healing scale and if possible photograph will be taken as a baseline reading. Subjects Pain assessment will be conducted at the same time using VAS. At the baseline subjects vitals will also be recorded.

The subjects will be evaluated again at Day 3  for any adverse event or any complications. If the wound site or the dressing site shows any discharge the dressing will be changed as per the standardized norms and suitable measures will be taken as per the PI discretion.

The subjects will be subsequently recalled at Day 6and the wound site will be evaluated by the Investigator the dressing will be re applied if the wound area requires so as per PI discretion

At Day 15 (End of Study) the subjects will be recalled and the wound site will be evaluated by the Investigator using wound healing scale and Pain will also be recorded using VAS.



---



---

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria
  • i)Subjects who are ready to give voluntary written informed consent.
  • ii)Both Male and female subjects between the age group of 18-60years iii)Subjects who undergone any major/ minor surgeries where the surgical wound need a dressing will be taken in to the study.
Exclusion Criteria

i)Subjects allergic to charcoal ii)Subjects who are unwilling to adhere to the study iii)Individual has a condition the Investigator believes would interfere with his or her ability to provide informed consent, comply with the study protocol, which might confound the interpretation of the study results or put the person at undue risk.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
i)The primary objective of this pilot study is to assess the efficacy of DRONAID (activated charcoal absorption gauge) over surgical wound.i)The primary objective of this pilot study is to assess the efficacy of DRONAID (activated charcoal absorption gauge) over surgical wound at day 15 | ii)Pain if any during the dressing change at day 15
ii)Pain if any during the dressing change at day 15i)The primary objective of this pilot study is to assess the efficacy of DRONAID (activated charcoal absorption gauge) over surgical wound at day 15 | ii)Pain if any during the dressing change at day 15
Secondary Outcome Measures
NameTimeMethod
i)The secondary objective is to evaluate the time taken for complete wound healingDay 3,Day 6 and Day 15

Trial Locations

Locations (1)

AIIMS Bhubaneswar

🇮🇳

Khordha, ORISSA, India

AIIMS Bhubaneswar
🇮🇳Khordha, ORISSA, India
Dr Pankaj
Principal investigator
9438884253
drpkushwaha@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.